Jan Sterz

1.2k total citations
24 papers, 945 citations indexed

About

Jan Sterz is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Jan Sterz has authored 24 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Oncology and 13 papers in Hematology. Recurrent topics in Jan Sterz's work include Peptidase Inhibition and Analysis (13 papers), Multiple Myeloma Research and Treatments (13 papers) and Ubiquitin and proteasome pathways (10 papers). Jan Sterz is often cited by papers focused on Peptidase Inhibition and Analysis (13 papers), Multiple Myeloma Research and Treatments (13 papers) and Ubiquitin and proteasome pathways (10 papers). Jan Sterz collaborates with scholars based in Germany, Greece and United States. Jan Sterz's co-authors include Ulrike Heider, Orhan Sezer, Martin Kaiser, Christian Jakob, Claudia Fleissner, Ivana Zavrski, Lorenz Kleeberg, Ivana von Metzler, Jessica Rademacher and Maren Mieth and has published in prestigious journals such as Blood, European Journal of Cancer and British Journal of Haematology.

In The Last Decade

Jan Sterz

21 papers receiving 924 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Sterz Germany 14 659 412 394 103 87 24 945
Sophie Derenne France 8 418 0.6× 362 0.9× 338 0.9× 88 0.9× 159 1.8× 11 780
Homare Eda United States 13 815 1.2× 480 1.2× 364 0.9× 61 0.6× 48 0.6× 29 1.0k
C. Vasselon France 11 625 0.9× 273 0.7× 420 1.1× 102 1.0× 127 1.5× 27 964
Alberto Rocci Italy 14 417 0.6× 170 0.4× 373 0.9× 53 0.5× 99 1.1× 32 661
Lorenz Kleeberg Germany 10 392 0.6× 359 0.9× 372 0.9× 39 0.4× 55 0.6× 16 674
Anuj Mahindra United States 17 703 1.1× 477 1.2× 918 2.3× 95 0.9× 116 1.3× 56 1.2k
Anand Jillella United States 12 456 0.7× 166 0.4× 379 1.0× 59 0.6× 136 1.6× 48 841
Simon Bomken United Kingdom 13 376 0.6× 366 0.9× 234 0.6× 113 1.1× 146 1.7× 32 964
Uta Bertsch Germany 15 852 1.3× 577 1.4× 920 2.3× 74 0.7× 73 0.8× 42 1.2k
Regine Leo Germany 9 430 0.7× 326 0.8× 478 1.2× 69 0.7× 139 1.6× 12 776

Countries citing papers authored by Jan Sterz

Since Specialization
Citations

This map shows the geographic impact of Jan Sterz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Sterz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Sterz more than expected).

Fields of papers citing papers by Jan Sterz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Sterz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Sterz. The network helps show where Jan Sterz may publish in the future.

Co-authorship network of co-authors of Jan Sterz

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Sterz. A scholar is included among the top collaborators of Jan Sterz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Sterz. Jan Sterz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lamottke, Britta, Martin Kaiser, Maren Mieth, et al.. (2012). The novel, orally bioavailable HSP90 inhibitor NVP‐HSP990 induces cell cycle arrest and apoptosis in multiple myeloma cells and acts synergistically with melphalan by increased cleavage of caspases. European Journal Of Haematology. 88(5). 406–415. 24 indexed citations
2.
Sterz, Jan, Christian Jakob, Ulrike Kuckelkorn, et al.. (2010). BSc2118 is a novel proteasome inhibitor with activity against multiple myeloma. European Journal Of Haematology. 85(2). 99–107. 11 indexed citations
3.
Jakob, Christian, Evangelos Terpos, Jan Sterz, et al.. (2009). Serum Levels of Total-RANKL in Multiple Myeloma. Clinical Lymphoma & Myeloma. 9(6). 430–435. 24 indexed citations
4.
Jakob, Christian, Jan Sterz, Ulrike Heider, et al.. (2009). An Angiogenic Risk Score Improves the Prognostic Information of the International Staging System in Patients with Symptomatic Multiple Myeloma.. Blood. 114(22). 2802–2802. 2 indexed citations
5.
6.
Sterz, Jan, Ivana von Metzler, Britta Lamottke, et al.. (2008). The potential of proteasome inhibitors in cancer therapy. Expert Opinion on Investigational Drugs. 17(6). 879–895. 102 indexed citations
7.
8.
Hecht, Monica, Ulrike Heider, Martin Kaiser, et al.. (2007). Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of p38 MAPK. British Journal of Haematology. 138(4). 446–458. 33 indexed citations
9.
Metzler, Ivana von, Holger Krebbel, Monica Hecht, et al.. (2007). Bortezomib inhibits human osteoclastogenesis. Leukemia. 21(9). 2025–2034. 152 indexed citations
10.
Heider, Ulrike, Ivana von Metzler, Martin Kaiser, et al.. (2007). Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma. European Journal Of Haematology. 80(2). 133–142. 86 indexed citations
11.
Zavrski, Ivana, Lorenz Kleeberg, Martin Kaiser, et al.. (2007). Proteasome as an Emerging Therapeutic Target in Cancer. Current Pharmaceutical Design. 13(5). 471–485. 44 indexed citations
12.
13.
Jakob, Christian, Jan Sterz, Ivana von Metzler, et al.. (2007). The Proteasome Inhibitor BSc2118 Causes Growth Inhibition, Cell Cycle Arrest and Cyclin D1 Degradation in Mantle Cell Lymphoma Cell Lines.. Blood. 110(11). 1401–1401. 1 indexed citations
14.
Jakob, Christian, Jan Sterz, Ivana Zavrski, et al.. (2006). Angiogenesis in multiple myeloma. European Journal of Cancer. 42(11). 1581–1590. 126 indexed citations
15.
Eucker, Jan, Jan Sterz, Holger Krebbel, et al.. (2006). Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma. Anti-Cancer Drugs. 17(7). 763–769. 19 indexed citations
16.
Jakob, Christian, Karl Egerer, Peter Liebisch, et al.. (2006). Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma. Blood. 109(5). 2100–2105. 104 indexed citations
17.
Sterz, Jan, Christian Jakob, Ulrike Kuckelkorn, et al.. (2006). BSc2118, a Novel Proteasome Inhibitor, Shows Anti-Tumor Activity in Multiple Myeloma and Mantle Cell Lymphoma.. Blood. 108(11). 3475–3475. 1 indexed citations
18.
Zavrski, Ivana, Monica Hecht, Holger Krebbel, et al.. (2006). Bortezomib Inhibits Human Osteoclastogenesis.. Blood. 108(11). 1395–1395. 8 indexed citations
19.
Heider, Ulrike, Martin Kaiser, Jan Sterz, et al.. (2005). Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma. European Journal Of Haematology. 76(1). 42–50. 66 indexed citations
20.
Heider, Ulrike, Martin Kaiser, Christian Müller, et al.. (2005). Treatment of Bortezomib Increases Osteoblast Function in Patients with Multiple Myeloma.. Blood. 106(11). 3457–3457. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sophie Derenne Breakdown of academic impact, for papers by Homare Eda Breakdown of academic impact, for papers by C. Vasselon Breakdown of academic impact, for papers by Alberto Rocci Breakdown of academic impact, for papers by Lorenz Kleeberg Breakdown of academic impact, for papers by Anuj Mahindra Breakdown of academic impact, for papers by Anand Jillella Breakdown of academic impact, for papers by Simon Bomken Breakdown of academic impact, for papers by Uta Bertsch Breakdown of academic impact, for papers by Regine Leo
Rankless by CCL
2026